4 insiders reported 11 Form 4 transactions for Apimeds Pharmaceuticals US, Inc. (APUS) over the past 18 months (most recent 2025-06-11). Recent activity: Inscobee Inc. (10% Owner) Buy 71,090 shares, Inscobee Inc. (10% Owner) Buy 44,041 shares, Emerson Erik C. (Chief Executive Officer) Buy 750,000 shares, Kim Christopher (Chairman and CMO) Buy 250,000 shares, Kim Christopher (Chairman and CMO) Buy 19,770 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-06-11 | Inscobee Inc. | 10% Owner | Buy | 71,090 | $184,834 |
| 2025-06-11 | Inscobee Inc. | 10% Owner | Buy | 44,041 | $114,507 |
| 2025-05-20 | Emerson Erik C. | Chief Executive Officer | Buy | 750,000 | $0 |
| 2025-05-20 | Kim Christopher | Chairman and CMO | Buy | 250,000 | $0 |
| 2025-05-15 | Kim Christopher | Chairman and CMO | Buy | 19,770 | $35,981 |
| 2025-05-15 | Kim Christopher | Chairman and CMO | Buy | 7,730 | $14,378 |
| 2025-05-14 | Inscobee Inc. | 10% Owner | Buy | 500,000 | $2.0M |
| 2025-05-14 | Inscobee Inc. | 10% Owner | Buy | 182,002 | $473,205 |
| 2025-05-14 | Inscobee Inc. | 10% Owner | Buy | 71,090 | $184,834 |
| 2025-05-14 | Inscobee Inc. | 10% Owner | Buy | 44,041 | $114,507 |
| 2025-05-14 | Koo Jakap | Director | Buy | 28,500 | $56,715 |
来源：SEC Form 4 申报文件 · 截至 2025-06-11